01:20am Wednesday 13 December 2017

Nano Global, Arm Collaborate on Artificial Intelligence Chip to Drive Health Revolution by Capturing and Analyzing Molecular Data in Real Time

AUSTIN, TX, USA – Nano Global, an Austin-based molecular data company, today announced that it is developing a chip using intellectual property (IP) from Arm, the world’s leading semiconductor IP company. The technology will help redefine how global health challenges – from superbugs to infectious diseases, and cancer are conquered.

The pioneering system-on-chip (SoC) will yield highly-secure molecular data that can be used in the recognition and analysis of health threats caused by pathogens and other living organisms. Combined with the company’s scientific technology platform, the chip leverages advances in nanotechnology[1], optics[2], artificial intelligence (AI)[3], blockchain authentication[4], and edge computing[5] to access and analyze molecular-level data in real time.

“In partnership with Arm, we’re tackling the vast frontier of molecular data to unlock the unlimited potential of this universe,” said Steve Papermaster, Chairman and CEO of Nano Global. “The data our technology can acquire and process will enable us to create a safer and healthier world.”

“We believe the technology Nano Global is delivering will be an important step forward in the collective pursuit of care that improves lives through the application of technology,” said Rene Haas, executive vice president and president of IPG, Arm. “By collaborating with Nano Global, Arm is taking an active role in developing and deploying the technologies that will move us one step closer to solving complex health challenges.”

Additionally, Nano Global will be partnering with several leading institutions, including Baylor College of Medicine and National University of Singapore, on broad research initiatives in clinical, laboratory, and population health environments to accelerate data collection, analysis, and product development.

The initial development of the chip is in process with first delivery expected by 2020. The company is already adding new partners to the platform.

For more information visit: www.nanoglobal.com.

 

Caption: Steve Papermaster, Chairman and CEO, Nano Global

 

Caption: Nano 3D Logo

 

+++Ends

 

Notes to editors:

Statistics on antimicrobial resistance / cancer

  • The annual cost to the US health care system of antibiotic-resistant infections is over US$ 20 billion (Source) (Source)
  • In the United States, Clostridium difficile (C.diff) alone is responsible for 250,000 infections and 14,000 deaths, adding US$ 1 billion dollars per year. (Source)
  • Superbugs could cause up to 10 million deaths per year by 2050. (Source)
  • Reports have shown that globally up to 700,000 people die of resistant infections every year. (Source)
  • In 2015, infectious diseases killed over 5.6 million people. (Source)
  • Cancer is the second leading cause of death globally, and was responsible for 8.8 million deaths in 2015. Globally, nearly 1 in 6 deaths is due to cancer. The number of new cases is expected to rise by about 70% over the next 2 decades. (Source)

 

All statistics are taken from reports compiled by the World Health Organisation (WHO), the US Centers for Disease Control and Prevention (CDC) and the UK government-funded Review on Antimicrobial Resistance (AMR).

 

Technology references:

[1] Nanotechnology is used in the engineering of the artificial intelligence chip as well as to develop solutions to health challenges.

[2] The optics include a combination of both microscopy and spectroscopy, utilized for molecular interaction data capture in real time.

[3] Artificial intelligence, including machine learning and vision, help identify patterns of molecular data discovered in order to predict trends, validate identifying markers, and uncover potential threats.

[4] Blockchain technology is utilized as a fundamental architectural element supporting data attribution, privacy, and security, as well as economic mechanisms.

[5] Edge computing enables highly-optimized, local processing and analysis of molecular data and relevant parameters in real time.

 

About Nano Global

NanoTM makes real-time molecular data addressable and scalable for a safer, healthier world. The company is redefining how human and environmental health challenges are conquered by making the world their laboratory. Nano was founded by CEO and Chairman, Steve Papermaster. It is headquartered in Austin, Texas, with teams in Singapore; Shanghai, China; and Bangalore, India. www.nanoglobal.com

 

NanoTM is a trademark of Nano Global – all other trademarks are of their respective owners.

 

Company contact:

Tommy Lynn

VP, Marketing and Brand, Nano Global

+1.737.443.8880

media@nanoglobal.com

www.nanoglobal.com

 

Media Contact:

Oliver Davies

Senior Director, Publitek

+44 1225 470 000

nanoglobal@publitek.com

www.publitek.com


Share on:
or:

MORE FROM Cancers

Health news